Animal Vaccines Market Share, Size, Trends, Industry Analysis Report, By Product (Attenuated Live Vaccines, Conjugate Vaccines, Inactivated Vaccines, Subunit Vaccines, Toxoid Vaccines, DNA Vaccines, Recombinant Vaccines); By Type; By Disease; By Route of

Animal Vaccines Market Share, Size, Trends, Industry Analysis Report, By Product (Attenuated Live Vaccines, Conjugate Vaccines, Inactivated Vaccines, Subunit Vaccines, Toxoid Vaccines, DNA Vaccines, Recombinant Vaccines); By Type; By Disease; By Route of Administration; By Region; Segment Forecast, 2023 - 2032



The global animal vaccines market size is expected to reach USD 31.07 billion by 2032, according to a new study by Polaris Market Research. The report “Animal Vaccines Market Share, Size, Trends, Industry Analysis Report, By Product (Attenuated Live Vaccines, Conjugate Vaccines, Inactivated Vaccines, Subunit Vaccines, Toxoid Vaccines, DNA Vaccines, Recombinant Vaccines); By Type; By Disease; By Route of Administration; By Region; Segment Forecast, 2022 - 2032” gives a detailed insight into current market dynamics and provides analysis on future market growth.

The rising prevalence of chronic and zoonotic diseases in animals, as well as the growing focus on animal healthcare and immunization, are predicted to propel the expansion of the global market for animal vaccines. The market for animal vaccinations is restrained, nonetheless, by the high storage costs connected with vaccines and the strict regulatory requirements. The market for animal vaccinations is growing, however, since more medicines are being introduced to immunize various species.

The demand for livestock vaccines is increasing due to growing concerns regarding improved animal husbandry and food security. The production of livestock has increased global impact in increasing animal product demand. Also, the need for animal products has increased, including population expansion and changing lifestyles. These elements promote market expansion. The emergence of animal diseases and the ongoing release of vaccinations using cutting-edge technology have also contributed to the changing market dynamics.

In 2022, the market expanded modestly. Animal vaccines have been influenced by the COVID-19 pandemic, as with all other sectors. The OIE has said that no animals can spread this virus during the earliest stages of the pandemic. Yet, a few nations have recorded cases of human-to-animal transfer. IDEXX Labs and other businesses tested many dogs and cats for the virus, but the results were negative. In the early stages of the pandemic, there was concern that it would be transmitted by birds, which harmed the cattle sector.

Animal Vaccines Market Report Highlights

In 2022, the segment of attenuated live vaccines produced the highest revenue. This type of vaccine can elicit a wider range of immune responses, resulting in improved immunity compared to traditional vaccines.

The animal vaccines market was dominated by the subcutaneous segment in 2022. Injection sites for this type of vaccine are typically located in the neck and behind the shoulder blades of the animal. The ease of administering subcutaneous medications, which are gradually absorbed by the body, is expected to contribute to the market's growth.

In 2022, the ruminant vaccines segment was the market leader, generating the highest revenue. This dominance can be attributed to several factors, including an increase in livestock numbers, favorable government initiatives, and the emergence of diseases affecting cattle and sheep.

In 2022, North America was the dominant market and generated the highest revenue. This can be attributed to the region's higher incidence of livestock and zoonotic diseases, important to significant animal mortality and increased demand for animal vaccines.

During the forecast period, Asia Pacific is expected to be the fastest-growing region for the global market due to government initiatives in emerging economies and significant poultry, aquaculture, and pork industries in countries such as China.

Polaris Market Research has segmented the Animal Vaccines Market report based on product, type, disease, route of administration, and region:

Animal Vaccines Market, Products Outlook (Revenue - USD Billion, 2019 - 2032)

Attenuated Live Vaccines

Conjugate Vaccines

Inactivated Vaccines

Subunit Vaccines

Toxoid Vaccines

DNA Vaccines

Recombinant Vaccines

Animal Vaccines Market, Type Outlook (Revenue - USD Billion, 2019 - 2032)

Poultry

Aqua

Companion

Canine

Feline

Avian

Equine

Bovine

Animal Vaccines Market, Disease Outlook (Revenue - USD Billion, 2019- 2032)

Swine Pneumonia

Avian Influenza

Rabies

Coccidiosis

Brucellosis

Distemper

Canine

Foot & Mouth

Strangles

Animal Vaccines Market, Route of Administration Outlook (Revenue - USD Billion, 2019- 2032)

Subcutaneous

Intramuscular

Intranasal

Animal Vaccines Market, Regional Outlook (Revenue - USD Billion, 2019 - 2032)

North America

U.S.

Canada

Europe

Germany

UK

France

Italy

Spain

Russia

Netherlands

Asia Pacific

China

India

Japan

South Korea

Indonesia

Malaysia

Latin America

Argentina

Brazil

Mexico

Middle East & Africa

UAE

Saudi Arabia

Israel

South Africa


1. Introduction
1.1. Report Description
1.1.1. Objectives of the Study
1.1.2. Market Scope
1.1.3. Assumptions
1.2. Stakeholders
2. Executive Summary
2.1. Market Highlights
3. Research Methodology
3.1. Overview
3.1.1. Data Mining
3.2. Data Sources
3.2.1. Primary Sources
3.2.2. Secondary Sources
4. Global Animal Vaccines Market Insights
4.1. Animal Vaccines – Industry Snapshot
4.2. Animal Vaccines Market Dynamics
4.2.1. Drivers and Opportunities
4.2.1.1. Outbreak of livestock diseases
4.2.1.2. Innovations in vaccine research
4.2.2. Restraints and Challenges
4.2.2.1. Associated side effects
4.3. Porter’s Five Forces Analysis
4.3.1. Bargaining Power of Suppliers (Moderate)
4.3.2. Threats of New Entrants: (Low)
4.3.3. Bargaining Power of Buyers (Moderate)
4.3.4. Threat of Substitute (Moderate)
4.3.5. Rivalry among existing firms (High)
4.4. PESTLE Analysis
4.5. Animal Vaccines Industry Trends
4.6. Value Chain Analysis
4.7. COVID-19 Impact Analysis
5. Global Animal Vaccines Market, by Products
5.1. Key Findings
5.2. Introduction
5.2.1. Global Animal Vaccines Market, by Products, 2019-2032 (USD Billion)
5.3. Attenuated Live Vaccines
5.3.1. Global Animal Vaccines Market, by Attenuated Live Vaccines, by Region, 2019-2032 (USD Billion)
5.4. Conjugate Vaccines
5.4.1. Global Animal Vaccines Market, by Conjugate Vaccines, by Region, 2019-2032 (USD Billion)
5.5. Inactivated Vaccines
5.5.1. Global Animal Vaccines Market, by Inactivated Vaccines, by Region, 2019-2032 (USD Billion)
5.6. Subunit Vaccines
5.6.1. Global Animal Vaccines Market, by Subunit Vaccines, by Region, 2019-2032 (USD Billion)
5.7. Toxoid Vaccines
5.7.1. Global Animal Vaccines Market, by Toxoid Vaccines, by Region, 2019-2032 (USD Billion)
5.8. DNA Vaccines
5.8.1. Global Animal Vaccines Market, by DNA Vaccines, by Region, 2019-2032 (USD Billion)
5.9. Recombinant Vaccines
5.9.1. Global Animal Vaccines Market, by Recombinant Vaccines, by Region, 2019-2032 (USD Billion)
6. Global Animal Vaccines Market, by Disease
6.1. Key Findings
6.2. Introduction
6.2.1. Global Animal Vaccines Market, by Disease, 2019-2032 (USD Billion)
6.3. Swine Pneumonia
6.3.1. Global Animal Vaccines Market, by Swine Pneumonia, by Region, 2019-2032 (USD Billion)
6.4. Avian Influenza
6.4.1. Global Animal Vaccines Market, by Avian Influenza, by Region, 2019-2032 (USD Billion)
6.5. Rabies
6.5.1. Global Animal Vaccines Market, by Rabies, by Region, 2019-2032 (USD Billion)
6.6. Coccidiosis
6.6.1. Global Animal Vaccines Market, by Coccidiosis, by Region, 2019-2032 (USD Billion)
6.7. Brucellosis
6.7.1. Global Animal Vaccines Market, by Brucellosis, by Region, 2019-2032 (USD Billion)
6.8. Distemper
6.8.1. Global Animal Vaccines Market, by Documents, by Region, 2019-2032 (USD Billion)
6.9. Canine
6.9.1. Global Animal Vaccines Market, by Canine, by Region, 2019-2032 (USD Billion)
6.10. Foot & Mouth
6.10.1. Global Animal Vaccines Market, by Foot & Mouth, by Region, 2019-2032 (USD Billion)
6.11. Strangles
6.11.1. Global Animal Vaccines Market, by Strangles, by Region, 2019-2032 (USD Billion)
7. Global Animal Vaccines Market, by Route of Administration
7.1. Key Findings
7.2. Introduction
7.2.1. Global Animal Vaccines Market, by Route of Administration, 2019-2032 (USD Billion)
7.3. Subcutaneous
7.3.1. Global Animal Vaccines Market, by Subcutaneous, by Region, 2019-2032 (USD Billion)
7.4. Intramuscular
7.4.1. Global Animal Vaccines Market, by Intramuscular, by Region, 2019-2032 (USD Billion)
7.5. Intranasal
7.5.1. Global Animal Vaccines Market, by Intranasal, by Region, 2019-2032 (USD Billion)
8. Global Animal Vaccines Market, by Type
8.1. Key Findings
8.2. Introduction
8.2.1. Global Animal Vaccines Market, by Type, 2019-2032 (USD Billion)
8.3. Poultry
8.3.1. Global Animal Vaccines Market, by Poultry, by Region, 2019-2032 (USD Billion)
8.4. Aqua
8.4.1. Global Animal Vaccines Market, by Aqua, by Region, 2019-2032 (USD Billion)
8.5. Companion
8.5.1. Global Animal Vaccines Market, by Companion, by Region, 2019-2032 (USD Billion)
8.5.2. Canine
8.5.2.1. Global Animal Vaccines Market, by Canine, by Region, 2019-2032 (USD Billion)
8.5.3. Feline
8.5.3.1. Global Animal Vaccines Market, by Feline, by Region, 2019-2032 (USD Billion)
8.6. Avian
8.6.1. Global Animal Vaccines Market, by Avian, by Region, 2019-2032 (USD Billion)
8.7. Equine
8.7.1. Global Animal Vaccines Market, by Equine, by Region, 2019-2032 (USD Billion)
8.8. Bovine
8.8.1. Global Animal Vaccines Market, by Bovine, by Region, 2019-2032 (USD Billion)
9. Global Animal Vaccines Market, by Geography
9.1. Key findings
9.2. Introduction
9.2.1. Animal Vaccines Market Assessment, By Geography, 2019-2032 (USD Billion)
9.3. Animal Vaccines Market – North America
9.3.1. North America: Animal Vaccines Market, by Products, 2019-2032 (USD Billion)
9.3.2. North America: Animal Vaccines Market, by Type, 2019-2032 (USD Billion)
9.3.3. North America: Animal Vaccines Market, by Disease, 2019-2032 (USD Billion)
9.3.4. North America: Animal Vaccines Market, by Route of Administration, 2019-2032 (USD Billion)
9.3.5. Animal Vaccines Market – U.S.
9.3.5.1. U.S.: Animal Vaccines Market, by Products, 2019-2032 (USD Billion)
9.3.5.2. U.S.: Animal Vaccines Market, by Type, 2019-2032 (USD Billion)
9.3.5.3. U.S.: Animal Vaccines Market, by Disease, 2019-2032 (USD Billion)
9.3.5.4. U.S.: Animal Vaccines Market, by Route of Administration, 2019-2032 (USD Billion)
9.3.6. Animal Vaccines Market – Canada
9.3.6.1. Canada: Animal Vaccines Market, by Products, 2019-2032 (USD Billion)
9.3.6.2. Canada: Animal Vaccines Market, by Type, 2019-2032 (USD Billion)
9.3.6.3. Canada: Animal Vaccines Market, by Disease, 2019-2032 (USD Billion)
9.3.6.4. Canada: Animal Vaccines Market, by Route of Administration, 2019-2032 (USD Billion)
9.4. Animal Vaccines Market – Europe
9.4.1. Europe: Animal Vaccines Market, by Products, 2019-2032 (USD Billion)
9.4.2. Europe: Animal Vaccines Market, by Type, 2019-2032 (USD Billion)
9.4.3. Europe: Animal Vaccines Market, by Disease, 2019-2032 (USD Billion)
9.4.4. Europe: Animal Vaccines Market, by Route of Administration, 2019-2032 (USD Billion)
9.4.5. Animal Vaccines Market – UK
9.4.5.1. UK: Animal Vaccines Market, by Products, 2019-2032 (USD Billion)
9.4.5.2. UK: Animal Vaccines Market, by Type, 2019-2032 (USD Billion)
9.4.5.3. UK: Animal Vaccines Market, by Disease, 2019-2032 (USD Billion)
9.4.5.4. UK: Animal Vaccines Market, by Route of Administration, 2019-2032 (USD Billion)
9.4.6. Animal Vaccines Market – France
9.4.6.1. France: Animal Vaccines Market, by Products, 2019-2032 (USD Billion)
9.4.6.2. France: Animal Vaccines Market, by Type, 2019-2032 (USD Billion)
9.4.6.3. France: Animal Vaccines Market, by Disease, 2019-2032 (USD Billion)
9.4.6.4. France: Animal Vaccines Market, by Route of Administration, 2019-2032 (USD Billion)
9.4.7. Animal Vaccines Market – Germany
9.4.7.1. Germany: Animal Vaccines Market, by Products, 2019-2032 (USD Billion)
9.4.7.2. Germany: Animal Vaccines Market, by Type, 2019-2032 (USD Billion)
9.4.7.3. Germany: Animal Vaccines Market, by Disease, 2019-2032 (USD Billion)
9.4.7.4. Germany: Animal Vaccines Market, by Route of Administration, 2019-2032 (USD Billion)
9.4.8. Animal Vaccines Market – Italy
9.4.8.1. Italy: Animal Vaccines Market, by Products, 2019-2032 (USD Billion)
9.4.8.2. Italy: Animal Vaccines Market, by Type, 2019-2032 (USD Billion)
9.4.8.3. Italy: Animal Vaccines Market, by Disease, 2019-2032 (USD Billion)
9.4.8.4. Italy: Animal Vaccines Market, by Route of Administration, 2019-2032 (USD Billion)
9.4.9. Animal Vaccines Market – Spain
9.4.9.1. Spain: Animal Vaccines Market, by Products, 2019-2032 (USD Billion)
9.4.9.2. Spain: Animal Vaccines Market, by Type, 2019-2032 (USD Billion)
9.4.9.3. Spain: Animal Vaccines Market, by Disease, 2019-2032 (USD Billion)
9.4.9.4. Spain: Animal Vaccines Market, by Route of Administration, 2019-2032 (USD Billion)
9.4.10. Animal Vaccines Market – Netherlands
9.4.10.1. Netherlands: Animal Vaccines Market, by Products, 2019-2032 (USD Billion)
9.4.10.2. Netherlands: Animal Vaccines Market, by Type, 2019-2032 (USD Billion)
9.4.10.3. Netherlands: Animal Vaccines Market, by Disease, 2019-2032 (USD Billion)
9.4.10.4. Netherlands: Animal Vaccines Market, by Route of Administration, 2019-2032 (USD Billion)
9.4.11. Animal Vaccines Market – Russia
9.4.11.1. Russia: Animal Vaccines Market, by Products, 2019-2032 (USD Billion)
9.4.11.2. Russia.: Animal Vaccines Market, by Type, 2019-2032 (USD Billion)
9.4.11.3. Russia: Animal Vaccines Market, by Disease, 2019-2032 (USD Billion)
9.4.11.4. Russia: Animal Vaccines Market, by Route of Administration, 2019-2032 (USD Billion)
9.5. Animal Vaccines Market – Asia Pacific
9.5.1. Asia Pacific: Animal Vaccines Market, by Products, 2019-2032 (USD Billion)
9.5.2. Asia Pacific: Animal Vaccines Market, by Type, 2019-2032 (USD Billion)
9.5.3. Asia Pacific: Animal Vaccines Market, by Disease, 2019-2032 (USD Billion)
9.5.4. Asia Pacific: Animal Vaccines Market, by Route of Administration, 2019-2032 (USD Billion)
9.5.5. Animal Vaccines Market – China
9.5.5.1. China: Animal Vaccines Market, by Products, 2019-2032 (USD Billion)
9.5.5.2. China.: Animal Vaccines Market, by Type, 2019-2032 (USD Billion)
9.5.5.3. China: Animal Vaccines Market, by Disease, 2019-2032 (USD Billion)
9.5.5.4. China: Animal Vaccines Market, by Route of Administration, 2019-2032 (USD Billion)
9.5.6. Animal Vaccines Market – India
9.5.6.1. India: Animal Vaccines Market, by Products, 2019-2032 (USD Billion)
9.5.6.2. India.: Animal Vaccines Market, by Type, 2019-2032 (USD Billion)
9.5.6.3. India: Animal Vaccines Market, by Disease, 2019-2032 (USD Billion)
9.5.6.4. India: Animal Vaccines Market, by Route of Administration, 2019-2032 (USD Billion)
9.5.7. Animal Vaccines Market – Japan
9.5.7.1. Japan: Animal Vaccines Market, by Products, 2019-2032 (USD Billion)
9.5.7.2. Japan.: Animal Vaccines Market, by Type, 2019-2032 (USD Billion)
9.5.7.3. Japan: Animal Vaccines Market, by Disease, 2019-2032 (USD Billion)
9.5.7.4. Japan: Animal Vaccines Market, by Route of Administration, 2019-2032 (USD Billion)
9.5.8. Animal Vaccines Market – Malaysia
9.5.8.1. Malaysia: Animal Vaccines Market, by Products, 2019-2032 (USD Billion)
9.5.8.2. Malaysia.: Animal Vaccines Market, by Type, 2019-2032 (USD Billion)
9.5.8.3. Malaysia: Animal Vaccines Market, by Disease, 2019-2032 (USD Billion)
9.5.8.4. Malaysia: Animal Vaccines Market, by Route of Administration, 2019-2032 (USD Billion)
9.5.9. Animal Vaccines Market – Indonesia
9.5.9.1. Indonesia: Animal Vaccines Market, by Products, 2019-2032 (USD Billion)
9.5.9.2. Indonesia.: Animal Vaccines Market, by Type, 2019-2032 (USD Billion)
9.5.9.3. Indonesia: Animal Vaccines Market, by Disease, 2019-2032 (USD Billion)
9.5.9.4. Indonesia: Animal Vaccines Market, by Route of Administration, 2019-2032 (USD Billion)
9.5.10. Animal Vaccines Market – South Korea
9.5.10.1. South Korea: Animal Vaccines Market, by Products, 2019-2032 (USD Billion)
9.5.10.2. South Korea.: Animal Vaccines Market, by Type, 2019-2032 (USD Billion)
9.5.10.3. South Korea: Animal Vaccines Market, by Disease, 2019-2032 (USD Billion)
9.5.10.4. South Korea: Animal Vaccines Market, by Route of Administration, 2019-2032 (USD Billion)
9.6. Animal Vaccines Market – Middle East & Africa
9.6.1. Middle East & Africa: Animal Vaccines Market, by Products, 2019-2032 (USD Billion)
9.6.2. Middle East & Africa: Animal Vaccines Market, by Type, 2019-2032 (USD Billion)
9.6.3. Middle East & Africa: Animal Vaccines Market, by Disease, 2019-2032 (USD Billion)
9.6.4. Middle East & Africa: Animal Vaccines Market, by Route of Administration, 2019-2032 (USD Billion)
9.6.5. Animal Vaccines Market – Saudi Arabia
9.6.5.1. Saudi Arabia: Animal Vaccines Market, by Products, 2019-2032 (USD Billion)
9.6.5.2. Saudi Arabia: Animal Vaccines Market, by Type, 2019-2032 (USD Billion)
9.6.5.3. Saudi Arabia: Animal Vaccines Market, by Disease, 2019-2032 (USD Billion)
9.6.5.4. Saudi Arabia: Animal Vaccines Market, by Route of Administration, 2019-2032 (USD Billion)
9.6.6. Animal Vaccines Market – South Africa
9.6.6.1. South Africa: Animal Vaccines Market, by Products, 2019-2032 (USD Billion)
9.6.6.2. South Africa: Animal Vaccines Market, by Type, 2019-2032 (USD Billion)
9.6.6.3. South Africa: Animal Vaccines Market, by Disease, 2019-2032 (USD Billion)
9.6.6.4. South Africa: Animal Vaccines Market, by Route of Administration, 2019-2032 (USD Billion)
9.6.7. Animal Vaccines Market – Israel
9.6.7.1. Israel: Animal Vaccines Market, by Products, 2019-2032 (USD Billion)
9.6.7.2. Israel: Animal Vaccines Market, by Type, 2019-2032 (USD Billion)
9.6.7.3. Israel: Animal Vaccines Market, by Disease, 2019-2032 (USD Billion)
9.6.7.4. Israel: Animal Vaccines Market, by Route of Administration, 2019-2032 (USD Billion)
9.6.8. Animal Vaccines Market – UAE
9.6.8.1. UAE: Animal Vaccines Market, by Products, 2019-2032 (USD Billion)
9.6.8.2. UAE: Animal Vaccines Market, by Type, 2019-2032 (USD Billion)
9.6.8.3. UAE: Animal Vaccines Market, by Disease, 2019-2032 (USD Billion)
9.6.8.4. UAE: Animal Vaccines Market, by Route of Administration, 2019-2032 (USD Billion)
9.7. Animal Vaccines Market – Latin America
9.7.1. Latin America: Animal Vaccines Market, by Products, 2019-2032 (USD Billion)
9.7.2. Latin America: Animal Vaccines Market, by Type, 2019-2032 (USD Billion)
9.7.3. Latin America: Animal Vaccines Market, by Disease, 2019-2032 (USD Billion)
9.7.4. Latin America: Animal Vaccines Market, by Route of Administration, 2019-2032 (USD Billion)
9.7.5. Animal Vaccines Market – Mexico
9.7.5.1. Mexico: Animal Vaccines Market, by Products, 2019-2032 (USD Billion)
9.7.5.2. Mexico: Animal Vaccines Market, by Type, 2019-2032 (USD Billion)
9.7.5.3. Mexico: Animal Vaccines Market, by Disease, 2019-2032 (USD Billion)
9.7.5.4. Mexico: Animal Vaccines Market, by Route of Administration, 2019-2032 (USD Billion)
9.7.6. Animal Vaccines Market – Brazil
9.7.6.1. Brazil: Animal Vaccines Market, by Products, 2019-2032 (USD Billion)
9.7.6.2. Brazil: Animal Vaccines Market, by Type, 2019-2032 (USD Billion)
9.7.6.3. Brazil: Animal Vaccines Market, by Disease, 2019-2032 (USD Billion)
9.7.6.4. Brazil: Animal Vaccines Market, by Route of Administration, 2019-2032 (USD Billion)
9.7.7. Animal Vaccines Market – Argentina
9.7.7.1. Argentina: Animal Vaccines Market, by Products, 2019-2032 (USD Billion)
9.7.7.2. Argentina: Animal Vaccines Market, by Type, 2019-2032 (USD Billion)
9.7.7.3. Argentina: Animal Vaccines Market, by Disease, 2019-2032 (USD Billion)
9.7.7.4. Argentina: Animal Vaccines Market, by Route of Administration, 2019-2032 (USD Billion)
10. Competitive Landscape
10.1. Expansion and Acquisition Analysis
10.1.1. Expansion
10.1.2. Acquisitions
10.2. Partnerships/Collaborations/Agreements/Exhibitions
11. Company Profiles
11.1. Biogénesis Bagó
11.1.1. Company Overview
11.1.2. Financial Performance
11.1.3. Product Benchmarking
11.1.4. Recent Development
11.2. Boehringer Ingelheim International GmbH
11.2.1. Company Overview
11.2.2. Financial Performance
11.2.3. Product Benchmarking
11.2.4. Recent Development
11.3. Elanco
11.3.1. Company Overview
11.3.2. Financial Performance
11.3.3. Product Benchmarking
11.3.4. Recent Development
11.4. Merck & Co., Inc
11.4.1. Company Overview
11.4.2. Financial Performance
11.4.3. Product Benchmarking
11.4.4. Recent Development
11.5. Ceva
11.5.1. Company Overview
11.5.2. Financial Performance
11.5.3. Product Benchmarking
11.5.4. Recent Development
11.6. Intas Pharmaceuticals Ltd
11.6.1. Company Overview
11.6.2. Financial Performance
11.6.3. Product Benchmarking
11.6.4. Recent Development
11.7. Indian Immunologicals Ltd
11.7.1. Company Overview
11.7.2. Financial Performance
11.7.3. Product Benchmarking
11.7.4. Recent Development
11.8. Neogen Corporation
11.8.1. Company Overview
11.8.2. Financial Performance
11.8.3. Product Benchmarking
11.8.4. Recent Development
11.9. Phibro Animal Health Corporation
11.9.1. Company Overview
11.9.2. Financial Performance
11.9.3. Product Benchmarking
11.9.4. Recent Development
11.10. Ourofino Saúde Animal
11.10.1. Company Overview
11.10.2. Financial Performance
11.10.3. Product Benchmarking
11.10.4. Recent Development
11.11. Virbac
11.11.1. Company Overview
11.11.2. Financial Performance
11.11.3. Product Benchmarking
11.11.4. Recent Development
11.12. Zoetis
11.12.1. Company Overview
11.12.2. Financial Performance
11.12.3. Product Benchmarking
11.12.4. Recent Development

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings